E. David Crawford

Title(s)Clinical Professor, Urology
SchoolVc-health Sciences-schools
Address9500 Gilman Drive #
La Jolla CA 92093
vCardDownload vCard

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Cases in the management of prostate cancer: the addition of darolutamide to androgen deprivation therapy and docetaxel in a 55-year-old man with metastatic hormone-sensitive prostate cancer. Clin Adv Hematol Oncol. 2022 07; 20 Suppl 14(7):1-8. Crawford ED. PMID: 35905311.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    2. Editorial Comment. J Urol. 2022 08; 208(2):324. Crawford ED. PMID: 35510427.
      View in: PubMed   Mentions:    Fields:    
    3. Darolutamide and Survival in Metastatic, Hormone-Sensitive Prostate Cancer. N Engl J Med. 2022 03 24; 386(12):1132-1142. Smith MR, Hussain M, Saad F, Fizazi K, Sternberg CN, Crawford ED, Kopyltsov E, Park CH, Alekseev B, Montesa-Pino Á, Ye D, Parnis F, Cruz F, Tammela TLJ, Suzuki H, Utriainen T, Fu C, Uemura M, Méndez-Vidal MJ, Maughan BL, Joensuu H, Thiele S, Li R, Kuss I, Tombal B, ARASENS Trial Investigators. PMID: 35179323.
      View in: PubMed   Mentions: 135     Fields:    Translation:HumansCTClinical Trials
    4. Editorial Comment. J Urol. 2021 11; 206(5):1175. Crawford ED. PMID: 34383587.
      View in: PubMed   Mentions:    Fields:    
    5. Editorial Comment. J Urol. 2021 10; 206(4):958. Crawford ED. PMID: 34259538.
      View in: PubMed   Mentions:    Fields:    
    6. Impact of Late Dosing on Testosterone Suppression with 2 Different Leuprolide Acetate Formulations: In Situ Gel and Microsphere. An Analysis of United States Clinical Data. J Urol. 2021 02; 205(2):554-560. Crawford ED, Hafron JM, Tagawa ST, Twardowski PW, Harris RG, Moul JW, Keane TE, Concepcion RS, Higano CS, Gordan LN, Petrylak DP, Cross CK, Kader AK, Shore ND. PMID: 33090917.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    7. Darolutamide: An Evidenced-Based Review of Its Efficacy and Safety in the Treatment of Prostate Cancer. Cancer Manag Res. 2020; 12:5667-5676. Crawford ED, Stanton W, Mandair D. PMID: 32765070; PMCID: PMC7367726.
      View in: PubMed   Mentions: 8  
    8. The role of FSH and LH in prostate cancer and cardiometabolic comorbidities. Can J Urol. 2020 04; 27(2):10167-10173. Crawford ED, Schally AV. PMID: 32333736.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    9. The Impact of Late Luteinizing Hormone-Releasing Hormone Agonist Dosing on Testosterone Suppression in Patients with Prostate Cancer: An Analysis of United States Clinical Data. J Urol. 2020 Apr; 203(4):743-750. Crawford ED, Twardowski PW, Concepcion RS, Hafron JM, Harris RG, Moul JW, Gordan LN, Petrylak DP, Atkinson SN, Boldt-Houle DM, Keane TE, Higano CS, Henderson RJ, Kader AK, Hussain MH, Shore ND. PMID: 31580749.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    10. The effect of bicycle riding on serum prostate specific antigen levels. J Urol. 1996 Jul; 156(1):103-5. Crawford ED, Mackenzie SH, Safford HR, Capriola M. PMID: 8648767.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    Elward's Networks
    Concepts (38)
    Derived automatically from this person's publications.
    Co-Authors (1)
    People in Profiles who have published with this person.
    Similar People (60)
    People who share similar concepts with this person.
    Same Department
    Search Department